By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Blueprint Medicines 

38 Sidney Street
Suite 200
Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-374-7580 Fax: n/a


SEARCH JOBS

Blueprint Medicines is developing a new generation of highly selective and potent kinase therapies to dramatically improve the lives of patients with genomically defined diseases.

Our approach is rooted in a deep understanding of the genetic blueprint of cancer and other diseases driven by the abnormal activation of kinases. We believe our ability to identify novel drivers of disease, coupled with our proprietary library of novel and diverse chemical compounds, uniquely enables us to craft kinase therapies against new and difficult-to-drug targets.

YEAR FOUNDED:

April 2011

LEADERSHIP:

CEO: Jeff Albers

CMO: Anthony L. Boral, M.D., PhD

CBO: Kate Haviland

CSO: Christoph Lengauer, PhD

JOBS:

Please click here for Blueprint job opportunities.

CLINICAL TRIAL:

Please click here for clinical trial information.


Key Statistics


Email: info@blueprintmedicines.com
Ownership: Public

Web Site: Blueprint
Employees:
Symbol: BPMC
 



Industry
Biotechnology






Company News
Currently No News Articles
//-->